Benzinga.com

NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting

MOUNTAIN VIEW, Calif., Jan. 7, 2022 /PRNewswire/ -- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the National Institute for Health and ...
Healio

Implantable ECG improves AF detection in patients with ischemic stroke

Please provide your email address to receive an email when new articles are posted on . In patients with ischemic stroke and no prior evidence of atrial fibrillation, implantable ECG monitoring for 12 ...
TCTMD

AI-ECG Strategy Identifies Patients at Risk for AF

Artificial intelligence (AI)-guided screening for atrial fibrillation (AF) based on ECGs can successfully identify patients who are more likely to have the arrhythmia detected on subsequent monitoring ...
Medscape

ECG Increases AF Detection, but Not Anticoagulation, After Stroke

Systematic ECG monitoring increased the in-hospital rate of atrial fibrillation (AF) detection among stroke survivors, in a new study. However, systematic ECG monitoring did not result in a higher ...
TCTMD

AMALFI: Modest AF Detection With ECG Patch Screening

MADRID, Spain—The use of a noninvasive ECG patch modestly increases the detection of atrial fibrillation (AF) and treatment with anticoagulant therapy among patients at moderate to high risk for ...
Business Wire

New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by ...
Healio

Manual review necessary to rule out AF in one-fourth of smartwatch ECG tracings

Please provide your email address to receive an email when new articles are posted on . An analysis of five ECG-capable smartwatches found comparable sensitivity and specificity for detection of ...
Business Wire

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug ...
Medscape

Remote ECG Screening Ups Atrial Fibrillation Detection ‘Modestly’

MADRID — A simple home-based screening strategy that involved wearing an ECG patch for 14 days increased the diagnosis of atrial fibrillation (AF) and associated use of anticoagulants in patients at ...
Nasdaq

Tempus Receives FDA 510(k) Clearance For Tempus ECG-AF To Detect Patients With AFib Risk

(RTTNews) - Tempus AI, Inc (TEM), Wednesday announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECF-AF, which utilizes AI to detect ...
News Medical

AMALFI trial finds small increase in AF diagnosis with mail-based ECG patch monitoring

A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in older patients at ...